학술논문

Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors
Document Type
Article
Source
In: Cancer. (Cancer, 15 June 2023, 129(12):1904-1918)
Subject
Language
English
ISSN
10970142
0008543X